Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Vaccine showed 82.6% overall vaccine efficacy against RSV-LRTD with 94.6% efficacy observed in adults with co-morbidities vii ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
“It blocked and neutralized almost 100% of all viruses and bacteria we tested, including Influenza, SARS-CoV-2, RSV, ...
A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect ...
A landmark study led by Duke-NUS Medical School revealed that despite the recent pandemic, outbreak detection efforts remain ...
In this GEN webinar, researchers from Vanderbilt University Medical Center describe recent advancements in therapeutic ...
While the debate continues about whether COVID-19 escaped from a biotech lab or emerged in a Wuhan wet market, a new study ...
A new study has revealed that despite the recent pandemic, outbreak detection efforts remain under-resourced in South and Southeast Asia, with only about half the countries reviewed having integrated ...
A new study led by Duke-NUS Medical School revealed that despite the recent pandemic, outbreak detection efforts remain under ...
When it comes to where the new variant has been detected, right now, it’s more common in Europe. Currently, it’s been ...